NCT04024449

Brief Summary

This case-control multicentre trial was performed from January 1, 2017, to May 31, 2018, in University of Health Sciences Bakirkoy Dr. Sadi Konuk Training and Research Hospital and Hitit University Hospital. Adolescents who were in compliance with the inclusion criteria were called by telephone for blood collection and ultrasound on the 3rd day of menstruation after approval from local ethical registration. On days 2-5 of the menstrual cycle, level of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), prolactin (PRL), and AMH were measured from venous blood samples in both groups. Antral Follicle Counts (AFCs) and ovarian volumes were determined on the same day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 10, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 18, 2019

Completed
Last Updated

July 18, 2019

Status Verified

July 1, 2019

Enrollment Period

1 year

First QC Date

July 10, 2019

Last Update Submit

July 17, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Anti mullerian Hormone (AMH)

    Level of AMH

    on Day 3 menstruation

  • Follicle Situmulating Hormone (FSH)

    Level of FSH

    on Day 3 menstruation

  • Ovarian Volume

    Ovarian volume measurement via Ultrasound

    on Day 3 menstruation

Study Arms (2)

Celiac Disease

Celiac disease with the following criteria; * 13 ≤ Age ≤20 * At least one year after menarche * Non-obesity or malnutrition, Non-Hyperandogenism symptoms, and blood tests, Non-Hyper or hypothyroidism, Non-Hyperprolactinemia.

Other: Group A

Control

The adolescent with the following criteria; * 13 ≤ Age ≤20 * At least one year after menarche * Non-obesity or malnutrition, Non-Hyperandogenism symptoms, and blood tests, Non-Hyper or hypothyroidism, Non-Hyperprolactinemia. * Control group; with normal menstrual period, Non-chronic diseases

Other: Group A

Interventions

Group AOTHER

ovarian function test in control group

Also known as: Celiac disease
Celiac DiseaseControl

Eligibility Criteria

Age13 Years - 20 Years
Sexfemale
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population included 37 subjects in total. 20 people were in patients with celiac disease, 17 people were healthy adolescents.

You may qualify if:

  • Celiac disease and control group with 13 ≤ Age ≤20
  • At least one year after menarche

You may not qualify if:

  • delayed menarche, early puberty, delayed puberty, delayed development of secondary sexual characters due to another sexual disorder, obesity or malnutrition, Hyperandrogenism symptoms, and blood tests, Hyper or hypothyroidism, Hyperprolactinemia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cihan Comba

Istanbul, 34000, Turkey (Türkiye)

Location

Related Publications (1)

  • Comba C, Comba A, Yilmaz H, Erdogan SV, Demir O. Celiac disease does not influence markers of ovarian reserve in adolescent girls. Arch Gynecol Obstet. 2020 Nov;302(5):1263-1269. doi: 10.1007/s00404-020-05666-4. Epub 2020 Jun 27.

MeSH Terms

Conditions

Celiac Disease

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Atakan Comba, M.D.

    Hitit University Department of Pediatric Gastroenterology

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
28 Days
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2019

First Posted

July 18, 2019

Study Start

January 1, 2017

Primary Completion

January 1, 2018

Study Completion

May 31, 2018

Last Updated

July 18, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will share

If the data is wanted, we will share data at any time.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations